Literature DB >> 3612637

Twin gestation and perinatal follow-up in a woman with severe chronic renal failure managed without dialysis. A case report.

A N Grunebaum, H Minkoff.   

Abstract

Severe renal insufficiency (serum creatinine greater than 2 mg/dL) during pregnancy has been associated with poor perinatal outcome. Even in the absence of maternal indications, hemodialysis has been suggested for fetal indications, although the influence of maternal renal failure on the newborn's development is unknown. The effects of the abnormal biochemical environment of dialysis on fetal growth and development are also unknown, and the small numbers of reported cases make it difficult to assess the indications for hemodialysis. A 35-year-old woman had a twin gestation and severe chronic renal failure. The pregnancy was managed without hemodialysis, and at 33 weeks' gestation two healthy newborns were delivered with cesarean section. Bailey scales of infant development at 14 months of age showed normal infant development. Hemodialysis is not indicated solely for fetal reasons in the patient with severe but stable renal failure in the absence of severe hypertension, pre-eclampsia, deteriorating renal status or intrauterine growth retardation.

Entities:  

Mesh:

Year:  1987        PMID: 3612637

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Multiple pregnancies in CKD patients: an explosive mix.

Authors:  Giorgina Barbara Piccoli; Silvana Arduino; Rossella Attini; Silvia Parisi; Federica Fassio; Marlisa Biolcati; Arianna Pagano; Carlotta Bossotti; Elena Vasario; Valentina Borgarello; Germana Daidola; Martina Ferraresi; Pietro Gaglioti; Tullia Todros
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

2.  Successful management of twin pregnancy in a woman with advanced chronic kidney disease: A case report.

Authors:  Yunbo Wei; Yan Wang; Qiang Yao; Li Zhou; Ping Fu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.